Electronic Health Records

Policy & Regulation News

More FAQs Address Meaningful Use Public Health Reporting

CMS Meaningful Use FAQs address public health reporting for Stage 1 participants and the use of PDMPs as specialized registries.

To continue to assist healthcare providers with the EHR Meaningful Use final rule, the Centers for Medicare & Medicaid Services (CMS) has released two more frequently asked questions pertaining to public health reporting.

meaningful use faq public health reporting

The first question addresses how Stage 1 participants can submit public health reporting:

For 2015, how should a provider report on the public health reporting objective if they had planned to be in Stage 1 meaningful use which required sending a test message and continued submission if successful, but did not require registration of intent?”

CMS explains that it does not intend for users to have to make meaningful use adjustments for 2015 considering the time at which the final rule was released. Since Stage 1 participants did not previously need to submit public health reports in 2015, submitting a test report or being in progress of a report is sufficient.

“Providers who have sent a test message can be considered to have met Option 2 of Active Engagement - Test and Validation; providers who are in production can be considered to have met Option 3 of Active Engagement - Production,” CMS explains.

The second question pertains to the use of prescription drug monitoring programs (PDMP) for as specialized registries.

CMS states that so long as the PDMP that is being integrated into the EHR is declared as a specialized registry within a certain jurisdiction, it will qualify.

“If the PDMP within a jurisdiction has declared itself a specialized registry ready to accept data, then the integration with a PDMP can count towards a specialized registry,” CMS says.

The PDMP will also have to be integrated onto a certified EHR system in order to qualify.

Continue to site...